期刊文献+

N,N-二甲氨基-3-氯丙烷氯化镁的合成工艺研究

The research of synthesis process about pharmaceutical intermediates 3-dimethylaminopropylchloride magnesiumchloride
下载PDF
导出
摘要 N,N-二甲氨基-3-氯丙烷氯化镁是合成氢溴酸西酞普兰重要的中间体。以N,N-二甲氨基-3-氯丙烷盐酸盐为初始原料,通过中和,合成N,N-二甲氨基-3-氯丙烷;在氮气保护条件下,以四氢呋喃为溶剂,N,N-二甲氨基-3-氯丙烷与镁粉作用,得到目标产物,反应总收率为70%。 3-Dimethylaminopropylchloride magnesiumchloride is an important pharmaceutical intermediatesin the synthesis of citalopram hydrobromide. 3-dimethylaminopropylchloride hydrochloride as the raw material, 3-dimethylaminopropylchloride was synthesized by the neutralization reaction.Tetrahydrofuran as solvent, in theprotection of nitrogen, target product were synthesized by 3- dimethylaminopropylchloride and magnesium, totalyield is 70%.
作者 高敏 许同桃 王月南 王换 周华 王倩 GAO Min XU Tong-tao WANG Yue-nan WANG Huan ZHOU Hua WANG Qian(Department of Chemical Engineering, Lianyungang Technical College, Lianyungang 22200)
出处 《天津化工》 CAS 2016年第5期7-9,共3页 Tianjin Chemical Industry
基金 2015江苏省大学生实践创新项目 2015年连云港市产学研联合项目(CXY1507)
关键词 氢溴酸西酞普兰 N N-二甲氨基-3-氯丙烷氯化镁 合成 citalopram hydrobromide 3-dimethylaminopropylchloride magnesiumchloride synthesis
  • 相关文献

参考文献11

二级参考文献42

  • 1吴秋业,廖洪利,赵惠清,叶光明,金永生.氢溴酸西酞普兰的合成[J].中国医药工业杂志,2005,36(1):6-8. 被引量:8
  • 2姚贵忠,刘平,舒良.西酞普兰治疗抑郁症的开放性研究[J].中国新药杂志,1997,6(3):170-173. 被引量:2
  • 3于靖涛(译) 田祖恩.抗抑郁药在老年人群中使用的药代动力学变化[J].精神医学论坛,2000,2:56-56.
  • 4赵和云.抗抑郁新药西酞普兰[N].中国医药报,2003-9-30.
  • 5Bogeso KP, Lyngby K, Toil AS,et al. Anti - depressive substituted 1 - dimethyl amino prepyl - 1 - phenyl - phthalans [ P ]. US :4136193,1979 - 01 - 23.
  • 6Pulla, Reddy, Muddasani. Process for the preparation of citalopram[ P]. WO :02066453,2002 - 08 - 29.
  • 7Killin, Stephen, James,et al. Improved process for the manufacture of citalopram hydrobromide from 5 - bromophthalide [ P ]. EP:1282211,2003 -03 -05.
  • 8Nandkumar C, Ajit B, Oak GM, et al. Process for the manufac-ture of citalopram hydrobromide from 5 - bromophthalide : [ P ]. US :2004077870,2004 - 04 - 22.
  • 9Muddasani, Pulla, Reddy, et al. Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts [ P]. US :2004016602,2004 - 02 - 26.
  • 10Jaweed M, Siddiqui, Mohammed, et al. Improved process for the manufacture of citalopram hydrobromide [ P ]. WO: 2005042473,2005 - 05 - 12.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部